Thermoregulatory effects of 3,4-methylenedioxymethamphetamine (MDMA) in humans

被引:90
|
作者
Freedman, RR
Johanson, CE
Tancer, ME
机构
[1] CS Mott Ctr, Detroit, MI 48201 USA
[2] Wayne State Univ, Sch Med, Dept Psychiat & Behav Neurosci, Detroit, MI 48201 USA
关键词
MDMA; body temperature; hyperthermia; metabolic rate; subjective effects;
D O I
10.1007/s00213-005-0149-6
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Rationale: Although 3,4-methylenedioxymeth-amphetamine (MDMA; Ecstasy) has been reported to cause fatal hyperthermia, few studies of the effects of MDMA on core body temperature in humans have been conducted demonstrating increased body temperature. In rats, MDMA causes hyperthermia at warm ambient temperatures but hypothermia at cold ones. Objectives: In this study, the physiological and subjective effects of MDMA in humans were determined at cold (18 degrees C) and warm (30 degrees C) ambient temperatures in a temperature and humidity-controlled laboratory. Methods: Ten healthy volunteers who were recreational users of MDMA were recruited. Four laboratory sessions were conducted in a 2x2 design [i.e., two sessions at 30 degrees C and two at 18 degrees C, two during MDMA (2 mg/kg, p.o.) and two during placebo, in double-blind fashion]. Core body temperature (ingested radiotelemetry pill), skin temperature (four weighted sites), heart rate, blood pressure, metabolic rate (indirect calorimetry), shivering (electromyogram levels), and sweat rate (capacitance hygrometry) were measured as well as subjective effects for several time periods following capsule ingestion. Results: MDMA produced significant elevations in core body temperature and metabolic rate in both warm and cold conditions. MDMA also produced significant elevations in blood pressure and heart rate and significantly increased several ratings of subjective effects similar to those previously reported. There were no differences related to ambient temperature for any of the subjective effects, except that ratings of cold and warm were appropriate to the ambient temperature and were not influenced by MDMA. Conclusions: Unlike findings in rats, MDMA increased core body temperature regardless of ambient temperature in humans. These increases appeared related to increases in metabolic rate, which were substantial. These findings warrant further investigations on the role of MDMA and other stimulants in altering metabolism and thermogenesis.
引用
收藏
页码:248 / 256
页数:9
相关论文
共 50 条
  • [31] BEHAVIORAL AND DEVELOPMENTAL EFFECTS OF 2 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA) DERIVATIVES
    BRONSON, ME
    BARRIOSZAMBRANO, L
    JIANG, WW
    CLARK, CR
    DERUITER, J
    NEWLAND, MC
    DRUG AND ALCOHOL DEPENDENCE, 1994, 36 (03) : 161 - 166
  • [32] The Agony of Ecstasy: MDMA (3,4-Methylenedioxymethamphetamine) and the Kidney
    Campbell, Garland A.
    Rosner, Mitchell H.
    CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2008, 3 (06): : 1852 - 1860
  • [33] Neuropsychological effects of 3,4-methylenedioxymethamphetamine (MDMA or ecstasy) in recreational users
    Back-Madruga, C
    Boone, K
    Chang, L
    Grob, C
    Poland, R
    Lee, A
    Nations, H
    ARCHIVES OF CLINICAL NEUROPSYCHOLOGY, 2003, 18 (07) : 720 - 720
  • [34] Effects of salicylate on 3,4-methylenedioxymethamphetamine (MDMA)-induced neurotoxicity in rats
    Yeh, SY
    PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR, 1997, 58 (03) : 701 - 708
  • [35] A Review of 3,4-methylenedioxymethamphetamine (MDMA)-Assisted Psychotherapy
    Sessa, Ben
    Higbed, Laurie
    Nutt, David
    FRONTIERS IN PSYCHIATRY, 2019, 10
  • [36] NEUROCHEMISTRY AND NEUROTOXICITY OF 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA, ECSTASY)
    MCKENNA, DJ
    PEROUTKA, SJ
    JOURNAL OF NEUROCHEMISTRY, 1990, 54 (01) : 14 - 22
  • [37] GLUCOCORTICOIDS AND 3,4-METHYLENEDIOXYMETHAMPHETAMINE (MDMA)-INDUCED NEUROTOXICITY
    JOHNSON, M
    STONE, DM
    BUSH, LG
    HANSON, GR
    GIBB, JW
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1989, 161 (2-3) : 181 - 188
  • [38] Adverse reactions with 3,4-methylenedioxymethamphetamine (MDMA; 'ecstasy')
    McCann, UD
    Slate, SO
    Ricaurte, GA
    DRUG SAFETY, 1996, 15 (02) : 107 - 115
  • [39] 3,4-methylenedioxymethamphetamine (MDMA, or ''ecstasy'') and associated hypoglycemia
    Montgomery, H
    Myerson, S
    AMERICAN JOURNAL OF EMERGENCY MEDICINE, 1997, 15 (02): : 218 - 218
  • [40] 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and driving impairment
    Logan, BK
    Couper, FJ
    JOURNAL OF FORENSIC SCIENCES, 2001, 46 (06) : 1426 - 1433